Skip to main content
Premium Trial:

Request an Annual Quote

Charles River Labs and GenOway to Co-Market Genetically Modified Research Models in Europe

NEW YORK, Nov. 23 (GenomeWeb News) - Charles River Laboratories and France-based GenOway will speed availability of genetically modified research models to their customers in Europe, the companies said this week.


Under the terms of the three-year agreement, Charles River Labs will market and promote GenOway's processes for developing research models, which include gene-expression and gene-inactivation techniques for mouse and rat models, the companies said.


Charles River Labs, which is based in Wilmington, Mass., said that it will market GenOway's technology to clients of its European Transgenic Services business. GenOway is based in Lyon.


The companies estimate that the agreement will result in a 45-percent shorter development time for such models while using the same budget as classical models, according to a statement.


Financial terms of the deal were not disclosed.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.